Hopital Haut-Leveque

Pessac, Aquitaine 33604

0 studies enrolling now · 4 studies all time

What they study most

ALK+ Advanced NSCLC, ALK-positive Advanced NSCLC, B-cell Non-Hodgkin Lymphoma (B-NHL), Diffuse Large B-cell Lymphoma

Studies at this site

• A Study to Assess the Anti-Tumor Activity and Safety of Odronextamab in Adult Patients With B-cell Non-Hodgkin Lymphoma Who Have Been Previously Treated With Other Cancer Therapies — Running, not enrolling
• A Study of Brigatinib Compared to Alectinib in Adults With Non-Small-Cell Lung Cancer — Completed
• A Study of Brigatinib in Participants With Anaplastic Lymphoma Kinase-Positive (ALK+), Advanced Non-Small-Cell Lung Cancer (NSCLC) Progressed on Alectinib or Ceritinib — Completed
• TAK-659 in Participants With Relapsed or Refractory Diffuse Large B-Cell Lymphoma (DLBCL) — Stopped early